Enveric Biosciences, Inc. - Common Stock, par value $0.01 per share (ENVB)

Historical Holders from Q1 2025 to Q3 2025

Symbol
ENVB on Nasdaq
Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
2,083,186
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
363,849
Holdings value
$232,604
% of all portfolios
0%
Number of holders
11
Number of buys
5
Number of sells
5
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Enveric Biosciences, Inc. - Common Stock, par value $0.01 per share (ENVB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
INTRACOASTAL CAPITAL, LLC 0.4% -92% $28,033 -$122,696 19,333 -81% Mitchell P. Kopin 18 Sep 2025
As of 30 Sep 2025 Enveric Biosciences, Inc. - Common Stock, par value $0.01 per share (ENVB) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 363,849 shares of 2,083,186 outstanding shares and own 17% of the company stock as of 30 Sep 2025.

Top 15 institutional shareholders of Enveric Biosciences, Inc. - Common Stock, par value $0.01 per share (ENVB) own 17% of the company based on 13F filings as of 30 Sep 2025

Filer Ownership Holdings Value Nb Shares Share Change %
AdvisorShares Investments LLC 9.8% $130,232 203,679 +96%
UBS Group AG 5.1% $67,309 105,333 +285%
GEODE CAPITAL MANAGEMENT, LLC 1.4% $18,229 28,510 +1.2%
CITADEL ADVISORS LLC 1.1% $14,498 22,674
Tower Research Capital LLC (TRC) 0.12% $1,546 2,418 -18%
BlackRock, Inc. 0.03% $384 601 0%
SBI Securities Co., Ltd. 0.03% $384 600 0%
BANK OF AMERICA CORP /DE/ 0% $17 26 +8.3%
NATIONAL BANK OF CANADA /FI/ 0% $3 5 0%
WELLS FARGO & COMPANY/MN 0% $1 2 0%
GROUP ONE TRADING LLC 0% $1 1 0%
Virtu Financial LLC 0% $0 0 -100%
RENAISSANCE TECHNOLOGIES LLC 0% $0 0 -100%
MORGAN STANLEY 0% $0 0 -100%
JONES FINANCIAL COMPANIES LLLP 0% $0 0 -100%

Institutional Holders of Enveric Biosciences, Inc. - Common Stock, par value $0.01 per share (ENVB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 363,849 $232,604 +$42,616 $0.6394 11
2025 Q2 234,158 $283,214 -$34,112 $1.21 14
2025 Q1 253,209 $344,649 +$344,651 $1.39 14